<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04950244</url>
  </required_header>
  <id_info>
    <org_study_id>VALIDATE</org_study_id>
    <nct_id>NCT04950244</nct_id>
  </id_info>
  <brief_title>Diagnostic Evaluation of Out-of-hospital High-sensitivity Troponin I in Patients Presenting Chest Pain</brief_title>
  <acronym>VALIDATE</acronym>
  <official_title>Diagnostic Evaluation of Out-of-hospital High-sensitivity Troponin I in Patients Presenting Chest Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Poitiers University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Poitiers University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Conducting an analysis of the clinical performance of high-sensitivity cardiac troponin I,&#xD;
      tested in the out-of-hospital setting, for ruling out cardiac origin in acute onset chest&#xD;
      pain.&#xD;
&#xD;
      Acute onset chest pain is a complex symptom to narrow down in the out-of-hospital setting.&#xD;
      This is due to the difficulty of obtaining pertinent information over the phone, and the&#xD;
      absence of validated dispatch scores or criteria.&#xD;
&#xD;
      In France, the current standard of care relies on the rapid dispatch of Emergency Medical&#xD;
      Response Teams along with a physician in patients presenting symptoms evocative of Coronary&#xD;
      Artery Disease or Myocardial Infarction.&#xD;
&#xD;
      Typical anginal pain includes retrosternal pressure pain radiating to the jaw, neck, or left&#xD;
      arm. Diagnostic work-up includes anamnesis, physical examination, routine blood work, and&#xD;
      ECG.&#xD;
&#xD;
      In the absence of signification ST-segment modifications, the gold standard relies on&#xD;
      trending serum Troponin T and I in the hospital setting .&#xD;
&#xD;
      This study aims to analyze the clinical performance of high-sensitivity cardiac Troponin I&#xD;
      assays (hs-cTnI) in the out-of-hospital setting using a point-of-care device ; Atellica VTLi&#xD;
      (Siemens Healthineers)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 5, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical performance of hs-cTnI for rule-out of cardiac origin of chest pain in the out of hospital setting</measure>
    <time_frame>3 hours</time_frame>
    <description>Determining the more appropriate cut off in terms of specificity and sensitivity to rule out chest pain in relation to coronary artery disease, based on the ROC curve.</description>
  </primary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Chest Pain</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>High-sensitivity cardiac troponin I (hs-cTnI)</intervention_name>
    <description>Capillary and veinous whole blood sampling for hs-cTnI was collected. The sample was tested at the bedside with a point-of-care device (Atellica VTLi, Siemens Healthineers).&#xD;
The result of both hs-c TnI values obtained was blinded to the treating physician</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        overall population of callers to the emergency dispatch center&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Over 18 years of age&#xD;
&#xD;
          -  Presenting with evocative acute onset chest pain&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  ECG modifications with ST segment elevations&#xD;
&#xD;
          -  Patients for whom anginal origin was excluded in the out-of-hospital setting&#xD;
&#xD;
          -  Medical evaluation in a delay inferior to 20 minutes&#xD;
&#xD;
          -  Patients without medical insurance&#xD;
&#xD;
          -  Pregnant or lactating women&#xD;
&#xD;
          -  Patients under reinforced guardianship, minors, patients in hospice care&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jérémy GUENEZAN, Hospital Practitioner</last_name>
    <phone>0549444444</phone>
    <phone_ext>46991</phone_ext>
    <email>jeremy.guenezan@chu-poitiers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sabrina SEGUIN, CRA</last_name>
    <phone>0549443229</phone>
    <email>sabrina.seguin@chu-poitiers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeremy GUENEZAN, Dr</last_name>
    </contact>
    <contact_backup>
      <last_name>raphael COUVREUR, dr</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 22, 2021</study_first_submitted>
  <study_first_submitted_qc>July 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>High-sensitivity cardiac Troponin I</keyword>
  <keyword>Troponin I HS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

